Notable Labs, Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NTBL research report →
Companywww.notablelabs.com
Notable Labs, Ltd. , a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic.
- CEO
- Kaile Zagger
- IPO
- 2014
- Employees
- 16
- HQ
- Or-Yehuda, IL
Price Chart
Valuation
- Market Cap
- $2.39M
- P/E
- -0.05
- P/S
- 7.72
- P/B
- 0.04
- EV/EBITDA
- 0.51
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 36.45%
- Op Margin
- -4728.06%
- Net Margin
- -3633.55%
- ROE
- -59.97%
- ROIC
- -84.60%
Growth & Income
- Revenue
- $310.00K · 3775.00%
- Net Income
- $-11,264,000 · 21.82%
- EPS
- $-5.03 · 22.62%
- Op Income
- $-14,657,000
- FCF YoY
- -17.96%
Performance & Tape
- 52W High
- $4.24
- 52W Low
- $0.22
- 50D MA
- $0.47
- 200D MA
- $0.92
- Beta
- -2.36
- Avg Volume
- 2.57M
Get TickerSpark's AI analysis on NTBL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 16, 24 | Zagger Kaile A. | other | 0 |
| May 8, 24 | Patsi Tuomo | other | 65,247 |
| May 8, 24 | Wagner Joseph P | other | 200,000 |
| May 8, 24 | Galen Michele | other | 40,247 |
| May 8, 24 | DUBIN THOMAS I H | other | 40,247 |
| May 8, 24 | Graney Thomas | other | 40,247 |
| May 8, 24 | Feinberg Peter | other | 40,247 |
| May 8, 24 | Bock Thomas | other | 400,000 |
| May 8, 24 | Bock Thomas | other | 150,000 |
| Jan 24, 24 | Feinberg Peter | other | 9,753 |
Our NTBL Coverage
We haven't published any research on NTBL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NTBL Report →